Supernus Pharmaceuticals SUPN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$29.02M-147% | -$38.55M-152% | -$19.12M-132% | $64.5M+1,131% | $61.91M+499% | ||
| $97.31M+21.6% | $91.56M+13.9% | $85.39M+2.6% | $80.69M-5.1% | $80.05M-5.8% | ||
| $33.46M+11.8% | $33.05M+19.1% | $31.03M+16.8% | $30.88M+15.2% | $29.93M+13.6% | ||
| —— | —— | —— | $187.06M+20.8% | $164.15M— | ||
| $1.01M+25.7% | $1.34M+84.6% | $1.12M+120% | $1.2M+159% | $804K+44.3% | ||
| —— | —— | —— | —— | -$100.93M— | ||
| $39.64M+468% | $9.13M-25.1% | $6.49M+3.0% | -$11.5M-484% | -$10.78M+97.7% | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Supernus Pharmaceuticals generate?
- Supernus Pharmaceuticals (SUPN) generated $175.5M in operating cash flow over the trailing twelve months.
- What is Supernus Pharmaceuticals's free cash flow?
- After $1.0M of capital expenditures, Supernus Pharmaceuticals's free cash flow was $174.3M over the trailing twelve months, up 1.8% year over year.
- Where does Supernus Pharmaceuticals's cash flow data come from?
- Every line is extracted from Supernus Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
